NASDAQ:ENTX Stock Quote
1.7500
+0.00 (0.00%)
Entera Bio Ltd is a biotechnology company focused on developing innovative oral drug delivery technologies to improve the treatment of various diseases, particularly in the areas of metabolic and endocrine disorders
By leveraging its proprietary platform, the company aims to create oral formulations of biologic drugs, which are traditionally administered via injections. Entera Bio's work includes the advancement of therapies designed to enhance patient compliance and reduce the burden of needle-based treatments, ultimately striving to provide effective and convenient options for those in need of advanced medical care.